Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Patients with type 2 diabetes who are about to begin, or who have recently begun, taking a GLP-1 drug should have a baseline dilated eye examination to determine their level of DR
These check-ins include reviewing weight loss progress, tracking any side effects, and addressing any concerns that may arise
This powerful approach can lead to significant and sustainable weight loss while also helping manage blood sugar in patients with type 2 diabetes
Research Evidence Comparison# Retatrutide Research# Phase 1 : First-in-human study established safety and pharmacokinetics Phase 2 (n=338) : Published in NEJM (2023), demonstrated dose-dependent weight loss up to 24.2% at 48 weeks with 12 mg dose
US$ 29.19
US$ 22.32
US$ 29.21
US$ 28.74
US$ 29.02
